Anavex Life Sciences Corp. (AVXL) Revenue History
Annual and quarterly revenue from 2014 to 2025
Compound Annual Growth Rate (CAGR)
Loading revenue history...
AVXL Revenue Growth
AVXL Revenue Analysis (2014–2025)
As of May 8, 2026, Anavex Life Sciences Corp. (AVXL) generated trailing twelve-month (TTM) revenue of $0. The most recent quarter (Q1 2026) recorded $0 in revenue.
Looking at the longer-term picture, AVXL's historical revenue data shows various trends over time.
When compared to Healthcare sector peers including ACAD (+9.9% YoY), and BIIB (+0.4% YoY). Compare AVXL vs ACAD →
AVXL Revenue vs Peers
Revenue metrics vs comparable public companies
| Company | TTM Revenue | YoY Growth | 5Y CAGR | Op. Margin | Compare |
|---|---|---|---|---|---|
| AVXLCurrent | $0 | - | - | - | |
 ACAD | $1.1B | +9.9% | +19.4% | 9.8% | |
 BIIB | $9.8B | +0.4% | -6.1% | 19.1% |
AVXL Historical Revenue Data (2014–2025)
| Year | Revenue | YoY % | Gross Profit | Gross Margin | Op. Income | Op. Margin |
|---|---|---|---|---|---|---|
| 2025 | $0 | - | $0 | - | $-51,408,000 | - |
| 2024 | $0 | - | $0 | - | $-52,877,000 | - |
| 2023 | $0 | - | $0 | - | $-55,756,000 | - |
| 2022 | $0 | - | $0 | - | $-50,986,000 | - |
| 2021 | $0 | - | $0 | - | $-41,921,000 | - |
| 2020 | $0 | +100.0% | $0 | - | $-31,088,232 | - |
| 2019 | $-685,000 | - | $0 | - | $-28,752,000 | 4197.4% |
| 2018 | $0 | - | $0 | - | $-19,185,000 | - |
| 2017 | $0 | - | $0 | - | $-15,539,000 | - |
| 2016 | $0 | - | $-1,252 | - | $-15,589,000 | - |
See AVXL's True Return
Price is only half the story. See total return with reinvested dividends.
Launch CalculatorIs AVXL Undervalued?
DCF intrinsic value, peer multiples, and analyst estimates — see what the stock is really worth.
View ValuationCompare AVXL vs DBVT
Side-by-side business, growth, and profitability comparison vs DBV Technologies S.A..
Start ComparisonAVXL — Frequently Asked Questions
Quick answers to the most common questions about buying AVXL stock.
Is AVXL's revenue growth accelerating or slowing?
AVXL TTM revenue: $0.00. YoY growth: N/A. 5-year CAGR: N/A.
What is AVXL's long-term revenue growth rate?
Anavex Life Sciences Corp.'s 5-year revenue CAGR of N/A reflects the variable expansion pattern. Current YoY growth of N/A is near this long-term average.
How is AVXL's revenue distributed by segment?
AVXL reports revenue by product line and geographic region. Annual and quarterly breakdowns from 2014-2025 are available for download. Segment mix reveals concentration and diversification trends.